Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://siobhanfmis633986.boyblogguide.com/37777577/semaglutide-a-potential-solution-for-metabolic-disorders